SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-K
FOR ANNUAL
AND TRANSITION REPORTS
PURSUANT TO SECTIONS 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2018.
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
FOR THE TRANSITION PERIOD FROM
TO
Commission File
No. 0-14902
MERIDIAN BIOSCIENCE, INC.
3471 River
Hills Drive
Cincinnati, Ohio 45244
IRS Employer ID
No. 31-0888197
Incorporated under the Laws of Ohio
Phone: (513)
271-3700
Securities Registered Pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
|
|
Name of each exchange of which
registered
|
Common Shares, No Par Value
|
|
The NASDAQ Stock Market LLC
|
|
|
(NASDAQ Global Select Market)
|
Securities Registered Pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the
registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☐ NO ☒
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or
15(d) of the Securities Exchange Act. YES ☐ NO ☒
Indicate by check mark
whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90
days. YES ☒ NO ☐
Indicate by check mark whether the registrant has
submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period
that the registrant was required to submit such files). YES ☒ NO ☐
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation SK (Section 229.405 of this Chapter) is not contained
herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10K or any amendment to this Form
10K. ☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or emerging growth company. See definitions of large accelerated filer, accelerated filer, smaller reporting company, and
emerging growth company in Rule
12b-2
of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer
|
|
☒
|
|
Accelerated filer
|
|
☐
|
|
|
|
|
Non-accelerated
filer
|
|
☐
|
|
Smaller reporting company
|
|
☐
|
|
|
|
|
Emerging growth company
|
|
☐
|
|
|
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule
12b-2). YES ☐ NO ☒
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
The aggregate market value of Common Shares held by
non-affiliates
as of March 31,
2018 was $592,033,599 based on a closing sale price of $14.20 per share on March 31, 2018. As of October 31, 2018, 42,402,912 no par value Common Shares were issued and outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of
the registrants proxy statement to be filed with the Commission for its 2019 Annual Shareholders Meeting are incorporated by reference in Part III as specified.